InsiderTrades

Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD

Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016719 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-07 2023-03-04+ TEVA Shani Eli EVP, Gbl Marketing, Portfolio M - OptEx — +29.2K 28.2K New —
D 2023-03-07 2023-03-03 TEVA Shani Eli EVP, Gbl Marketing, Portfolio A - Grant $0.00 +59.8K 59.8K New $0
DM 2023-03-07 2023-03-04+ TEVA Shani Eli EVP, Gbl Marketing, Portfolio M - OptEx $0.00 -29.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2023-03-04 M A 20,107 — 48,332 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
2 Common Ordinary Shares 2023-03-05 M A 5,896 — 54,228 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
3 Common Ordinary Shares 2023-03-04 M A 3,173 — 28,225 D — — (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
4 Derivative Restricted Share Units 2023-03-03 A A 59,760 $0.00 59,760 D — · — to — 59,760 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027.
5 Derivative Restricted Share Units 2023-03-04 M D 20,107 $0.00 60,321 D — · — to — 20,107 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
6 Derivative Restricted Share Units 2023-03-05 M D 5,896 $0.00 11,794 D — · — to — 5,896 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 5, 2021, with 5,896 vested on each of March 5, 2022 and March 5, 2023, 5,896 vesting on March 5, 2024, and 5,898 vesting on March 5, 2025.
7 Derivative Restricted Share Units 2023-03-04 M D 3,173 $0.00 0 D — · — to — 3,173 Ordinary Shares (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2019, with 3,173 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023.